Tonix Pharma (TNXP) Tops Q2 EPS by 297c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($3.86), $2.97 better than the analyst estimate of ($6.83). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.55 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Stifel on Bally's Corp (BALY): 'expect shares to continue to trade mainly on development project cost & financing updates'
• L3Harris CEO steps down amid conduct review, shares drop